{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:45:06Z","timestamp":1761489906901,"version":"3.40.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.01.055","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T17:47:07Z","timestamp":1455040027000},"page":"1459-1464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0620-6451","authenticated-orcid":false,"given":"Ashley L.","family":"Fowlkes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy","family":"Beeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susette A.","family":"Audet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Broadhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicity","family":"Cutts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita F.","family":"Helfand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.01.055_bib0090","first-page":"349","article-title":"Measles vaccines: WHO position paper","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1086\/421032","article-title":"Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States","volume":"190","author":"Gans","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/infdis\/165.2.262","article-title":"Increased risk of early measles in infants of human immunodeficiency virus type 1-seropositive mothers","volume":"165","author":"Embree","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0105","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.vaccine.2005.01.092","article-title":"Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age","volume":"23","author":"Carson","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0110","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0264-410X(00)00431-X","article-title":"Measles antibody responses after early two dose trials in Guinea\u2013Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston\u2013Zagreb vaccine","volume":"19","author":"Garly","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/jiu117","article-title":"Measles virus antibody responses in children randomly assigned to receive standard-titer Edmonston\u2013Zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age","volume":"210","author":"Martins","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0120","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/592756","article-title":"Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi","volume":"198","author":"Helfand","year":"2008","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.01.055_bib0125","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1093\/infdis\/jir135","article-title":"Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston\u2013Zagreb measles vaccine among HIV-infected and uninfected children in Malawi","volume":"204","author":"Fowlkes","year":"2011","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.01.055_bib0130","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1093\/infdis\/jir071","article-title":"Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity","volume":"204","author":"Scott","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00002030-199802000-00010","article-title":"Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi","volume":"12","author":"Taha","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0145","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/j.vaccine.2012.01.083","article-title":"Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years","volume":"30","author":"Njie-Jobe","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0150","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/infdis\/jit804","article-title":"A randomized trial of a standard dose of Edmonston\u2013Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions","volume":"209","author":"Martins","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0155","doi-asserted-by":"crossref","first-page":"c6495","DOI":"10.1136\/bmj.c6495","article-title":"Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial","volume":"341","author":"Aaby","year":"2010","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00006454-199002000-00008","article-title":"Duration of live measles vaccine-induced immunity","volume":"9","author":"Markowitz","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/519169","article-title":"Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study","volume":"196","author":"Moss","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.055_bib0170","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1473-3099(10)70116-X","article-title":"Do children infected with HIV receiving HAART need to be revaccinated","volume":"10","author":"Sutcliffe","year":"2010","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T11:23:27Z","timestamp":1537010607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16001183"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}